The path to Crohn's disease: Is mucosal pathology a secondary event

Inflammatory Bowel Diseases

Volumn 16, Issue 5, 2010, Pages 896-902

  Behr, Marcel A ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Crohn's disease; Mucosal damage; Pathogenesis

Indexed keywords

ACUTE GASTROENTERITIS; CHRONIC INFLAMMATION; CROHN DISEASE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ENTERITIS; GASTROINTESTINAL TRACT; GENETIC ANALYSIS; HUMAN; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE MUCOSA; INTRACELLULAR BACTERIUM; LISTERIA MONOCYTOGENES; LYMPHOID TISSUE; MACROPHAGE; MESENTERY; MYCOBACTERIUM; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; RELAPSE; REVIEW; SALMONELLA; ULCERATIVE COLITIS;

BACTERIA; BACTERIAL INFECTIONS; CROHN DISEASE; HUMANS; INTESTINAL MUCOSA;

EID: 77950639454     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21171     Document Type: Review

References (58)

1. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006;314:1461-1463.
2. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1, Nat Genet. 2007;39:207-211. (Pubitemid 46184351)
3. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603.
4. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001; 411:603-606.
5. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007;39:596-604.
6. Iyer VR, Eisen MB, Ross DT, et al. The transcriptional program in the response of human fibroblasts to serum. Science. 1999;283:83-87.
7. Satsangi. J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753.
8. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627-1640.
9. Korzenik. JR. Is Crohn's disease due to defective immunity? Gut. 2007;56:2-5. (Pubitemid 46044879)
10. Round JL, Mazmanian SK, The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009; 9:313-323.
11. Marks DJ, Harbord MW, MacAllister R, et al. Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet. 2006;367: 668-678.
12. Segal AW, Loewi G. Neutrophil dysfunction in Crohn's disease. Lancet. 1976;2:219-221.
13. Marciano BE, Rosenzweig SD, Kleiner DE, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114: 462-468.
14. Casanova JL, Abel L. Revisiting Crohn's disease as a primary immunodeficiency of macrophages. J Exp Med. 2009;206:1839-1843.
15. Coulombe F, Behr MA. Crohn's disease as an immune deficiency? Lancet. 2009;374:769-770.
16. Parkes M, Barrett JC, Prescott NJ, et al. Sequence variants in the autophagy gene IRGM. and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet. 2007;39:830-832.
17. Bieber D, Ramer SW, Wu CY, et al. Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli. Science. 1998;280:2114-2118.
18. Vallance BA, Finlay BB. Exploitation of host cells by enteropathogenic Escherichia coli. Proc Natl Acad Sci U S A. 2000:97:8799-8806. (Pubitemid 30626629)
19. Guttman JA, Finlay BB. Subcellular alterations that lead to diarrhea during bacterial pathogenesis. Trends Microbiol. 2008;16:535-542.
20. Strober W. Animal models of inflammatory bowel disease-an overview. Dig Dis Sci. 1985;30:3S-10S.
21. Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am. 1995; 24:475-507.
22. Xavier RJ, Rioux JD. Genome-wide association studies: a new window into immune-mediated diseases. Nat Rev Immunol. 2008;8:631-643.
23. Economou M, Pappas G. New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis. 2008;14:709-720.
24. Hugot JP. CARD15/NOD2 mutations in Crohn's disease. Ann N Y Acad Sci. 2006;1072:9-18.
25. Pascoe L, Zouali H, Sahbatou M, et al. Estimating the odds ratios of Crohn disease for the main CARD15/NOD2 mutations using a conditional maximum likelihood method in pedigrees collected via affected family members. Eur J Hum Genet. 2007;15:864-871.
26. Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307:731-734.
27. Pauleau AL, Murray PJ. Role of Nod2 in the response of macrophages to Toll-like receptor agonists. Mol Cell Biol. 2003;23:7531-7539.
28. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol. 2008;8:458-466.
29. Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003;278:8869-8872.
30. Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem. 2003;278:5509-5512.
31. Feng CG, Collazo-Custodio CM, Eckhaus M, et al. Mice deficient in LRG47 display increased susceptibility to mycobacterial infection associated with the induction of lymphopenia. J Immunol. 2004;172:1163-1168.
32. Gutierrez MG, Master SS, Singh SB, et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell. 2004;119:753-766.
33. MacMicking JD. Immune control of phagosomal bacteria by p47 GTPases. Curr Opin Microbiol. 2005;8:74-82.
34. MacMicking JD, Taylor GA, McKinney JD. Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science. 2003;302:654-659.
35. Smith AM, Rahman FZ, Hayee B, et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med. 2009;206:1883-1897.
36. Penack O, Smith OM, Cunningham-Bussel A, et al. NOD2 regulates hematopoietic cell function during graft-versus-host disease. J Exp Med. 2009;206:2101-2110.
37. Lecuit M, Dramsi S, Gottardi C, et al. A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes. EMBO J. 1999;18:3956-3963.
38. Disson O, Grayo S, Huillet E, et al. Conjugated action of two speciesspecific invasion proteins for fetoplacental listeriosis. Nature. 2008; 455:1114-1118.
39. Lecuit M, Vandormael-Pournin S, Lefort J, et al. A transgenic model for listeriosis: role of internalin in crossing the intestinal barrier. Science. 2001;292:1722-1725.
40. Barthel M, Hapfelmeier S, Quintanilla-M.artinez L, et al. Pretreatment of mice with streptomycin provides a Salmonella entérica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun. 2003;71:2839-2858.
41. Wu CW, Livesey M, Schmoller SK, et al. Invasion and persistence of Mycobacterium avium subsp. paratuberculosis during early stages of Johne's disease in calves. Infect Immun. 2007;75:2110-2119.
42. Kluge JP, Merkal RS, Monlux WS, et al. Experimental paratuberculosis in sheep after oral, intratracheal, or intravenous inoculation lesions and demonstration of etiologic agent. Am J Vet Res. 1968;29:953-962.
43. Van Kruiningen HJ, Colombel JF. The forgotten role of lymphangitis in Crohn's disease. Gut. 2008;57:1-4.
44. Rutgeerts P, Geboes K, Vantrappen G, et al. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut. 1984;25:665-672.
45. Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet. 1991;338:771-774.
46. Barnich N, Carvalho FA, Classer AL, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest. 2007;117:1566-1574.
47. Abraham. C, Cho JH, Bugging of the intestinal mucosa. N Engl J Med. 2007;357:708-710.
48. Autschbach F, Eisold S, Hinz U, et al. High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease. Gut. 2005;54:944-949. (Pubitemid 40873906)
49. Frank DN, St Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104: 13780-13785.
50. Kuballa P, Huett A, Rioux JD, et al. Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant. PLoS ONE. 2008;3:e3391.
51. Keane J, Remold HG, Kornfeld H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol. 2000;164:2016-2020.
52. Stanley SA, Raghavan S, Hwang WW, et al. Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc Natl Acad Sci U S A. 2003; 100:13001-13006.
53. Sturgill-Koszycki S, Schaible UE, Russell DG. Mycobacterium-containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis. EMBO J. 1996;15: 6960-6968.
54. Grassl GA, Valdez Y, Bergstrom KS, et al. Chronic enteric salmonella infection in mice leads to severe and persistent intestinal fibrosis. Gastroenterology. 2008;134:768-780.
55. Monack DM, Bouley DM, Falkow S. Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice and can be reactivated by IFNgamma neutralization. J Exp Med. 2004;199:231-241. (Pubitemid 38129703)
56. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, et al. Assessment of Crohn's disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur Radiol. 2004;14:1017-1024.
57. Peyrin-Biroulet L, Chamaillard M, Gonzalez F, et al. Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander? Gut. 2007;56:577-583.
58. Pierce ES. Where are all the Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease? PLoS Pathog. 2009;5: e1000234.